TLS Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

TLS Advisors’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-199	Closed	-$52K	–	19
2022 Q4	$52K	Buy	+199	New	+$53.5K	0.26%	19

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

TLS Advisors's APTO Position: Q1 2023 in Review

TLS Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q1 2023, closing a stake of 199 shares — an estimated $52K sold.

TLS Advisors first reported a position in APTO in Q4 2022 and held it in 1 quarter. The position peaked at $52K in Q4 2022. 44 funds tracked by Wall St. Rank hold APTO as of Q1 2023.

TLS Advisors reported no remaining Aptose Biosciences, Inc. position as of Q1 2023 after selling out during the quarter.
TLS Advisors sold 199 Aptose Biosciences, Inc. shares in Q1 2023, an estimated $52K.
TLS Advisors first reported a position in Aptose Biosciences, Inc. in Q4 2022 and held it in 1 quarter.
TLS Advisors's Aptose Biosciences, Inc. position peaked at $52K in Q4 2022.
44 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2023.

Based on TLS Advisors's 13F filing for Q1 2023, filed 16 Nov 2023.